Page last updated: 2024-10-27

flurbiprofen and Dermatitis Herpetiformis

flurbiprofen has been researched along with Dermatitis Herpetiformis in 1 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Dermatitis Herpetiformis: Rare, chronic, papulo-vesicular disease characterized by an intensely pruritic eruption consisting of various combinations of symmetrical, erythematous, papular, vesicular, or bullous lesions. The disease is strongly associated with the presence of HLA-B8 and HLA-DR3 antigens. A variety of different autoantibodies has been detected in small numbers in patients with dermatitis herpetiformis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tousignant, J1
Lafontaine, N1
Rochette, L1
Rozenfarb, E1

Other Studies

1 other study available for flurbiprofen and Dermatitis Herpetiformis

ArticleYear
Dermatitis herpetiformis induced by nonsteroidal anti-inflammatory drugs.
    International journal of dermatology, 1994, Volume: 33, Issue:3

    Topics: Adult; Dermatitis Herpetiformis; Flurbiprofen; Humans; Ibuprofen; Immunoglobulin A; Keratinocytes; M

1994